![John Blodgett Edwards](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Blodgett Edwards
Directeur Général chez
Verseau Therapeutics, Inc.
Profil
John Blodgett Edwards is currently the Chief Executive Officer at Verseau Therapeutics, Inc. He also holds director positions at Avaxia Biologics, Inc., F-star Alpha Ltd., and F-Star Beta Ltd. Edwards has previously held executive chairman positions at ImmuneXcite, Inc., Tilos Therapeutics, Inc., and Abcuro, Inc. He has also served as a non-executive director at F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH and as an independent non-executive director at F-star Biotechnology Ltd. Additionally, Edwards has held director positions at Permeon Biologics, Inc. and Exonics Therapeutics, Inc. He has also worked as an Assistant VP-Global Strategic Marketing at Genetics Institute LLC, Vice President-Sales, Marketing & Medical Affairs at Transkaryotic Therapies, Inc., and as a Principal at Wyeth Pharmaceuticals LLC.
Edwards was the President of Adnexus from 2004 to 2011.
He holds an MBA from Boston University and an undergraduate degree from the University of Massachusetts.
Postes actifs de John Blodgett Edwards
| Sociétés | Poste | Début |
|---|---|---|
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Directeur/Membre du Conseil | - |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Directeur/Membre du Conseil | - |
F-Star Beta Ltd.
 F-Star Beta Ltd. BiotechnologyHealth Technology Researches and develops oncology and immuno-oncology compounds | Directeur/Membre du Conseil | 14/10/2014 |
Verseau Therapeutics, Inc.
 Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides immuno-therapy services | Directeur Général | 26/05/2021 |
Anciens postes connus de John Blodgett Edwards
| Sociétés | Poste | Fin |
|---|---|---|
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | President | - |
Abcuro, Inc.
 Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Président | - |
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Président | - |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Directeur/Membre du Conseil | - |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Président | - |
Formation de John Blodgett Edwards
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
Avaxia Biologics, Inc.
Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Permeon Biologics, Inc.
 Permeon Biologics, Inc. BiotechnologyHealth Technology Develops intracellular biotherapeutics platform to enhance drug delivery | Health Technology |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Health Technology |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Tilos Therapeutics, Inc.
Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Health Technology |
F-Star Beta Ltd.
F-Star Beta Ltd. BiotechnologyHealth Technology Researches and develops oncology and immuno-oncology compounds | Health Technology |
Abcuro, Inc.
Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Commercial Services |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides immuno-therapy services | Commercial Services |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
